The hyaluronan/CD44 axis: a double-edged sword in cancer
N Cirillo - International Journal of Molecular Sciences, 2023 - mdpi.com
Hyaluronic acid (HA) receptor CD44 is widely used for identifying cancer stem cells and its
activation promotes stemness. Recent evidence shows that overexpression of CD44 is …
activation promotes stemness. Recent evidence shows that overexpression of CD44 is …
Aptamers as potential therapeutic tools for ovarian cancer: Advancements and challenges
W Szymanowski, A Szymanowska, A Bielawska… - Cancers, 2023 - mdpi.com
Simple Summary Aptamers are versatile molecules for cancer treatment. They can be used
to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In …
to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In …
A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients
K Yuan, S Zhao, B Ye, Q Wang, Y Liu… - Frontiers in …, 2023 - frontiersin.org
The phenomenon of T Cell exhaustion (TEX) entails a progressive deterioration in the
functionality of T cells within the immune system during prolonged conflicts with chronic …
functionality of T cells within the immune system during prolonged conflicts with chronic …
Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells
R El Baba, S Haidar Ahmad, F Monnien, R Mansar… - Oncogene, 2023 - nature.com
Human cytomegalovirus (HCMV) infection has been implicated in epithelial ovarian cancer
(OC). Polyploidy giant cancer cells (PGCCs) have been observed in high-grade serous …
(OC). Polyploidy giant cancer cells (PGCCs) have been observed in high-grade serous …
Ginsenoside Rh1 prevents migration and invasion through mitochondrial ROS-mediated inhibition of STAT3/NF-κB signaling in MDA-MB-231 cells
Breast cancer (BC) a very common cancer in women worldwide. Triple negative breast
cancer (TNBC) has been shown to have a poor prognosis with a high level of tumor …
cancer (TNBC) has been shown to have a poor prognosis with a high level of tumor …
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
L Wiedmann, F De Angelis Rigotti… - Nature …, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) frequently metastasizes into the peritoneum,
which contributes to poor prognosis. Metastatic spreading is promoted by cancer cell …
which contributes to poor prognosis. Metastatic spreading is promoted by cancer cell …
Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
N Iżycka, MP Zaborowski, Ł Ciecierski, K Jaz… - International Journal of …, 2023 - mdpi.com
Cancer stem cells (CSCs) may contribute to an increased risk of recurrence in ovarian
cancer (OC). Further research is needed to identify associations between CSC markers and …
cancer (OC). Further research is needed to identify associations between CSC markers and …
[HTML][HTML] Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells
GP Zou, CX Yu, SL Shi, QG Li, XH Wang, XH Qu… - Journal of …, 2021 - ncbi.nlm.nih.gov
Cisplatin (DDP) is the first-line chemotherapeutic agent for ovarian cancer. However, the
development of DDP resistance seriously influences the chemotherapeutic effect and …
development of DDP resistance seriously influences the chemotherapeutic effect and …
Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
Abstract Background Cancer stem cells (CSCs) are crucial for the growth, metastasis, drug
resistance, recurrence, and spread of tumors. Napabucasin (NAP) could effectively inhibit …
resistance, recurrence, and spread of tumors. Napabucasin (NAP) could effectively inhibit …
Therapeutic strategies for targeting ovarian cancer stem cells
W Yang, D Kim, DK Kim, KU Choi, DS Suh… - International Journal of …, 2021 - mdpi.com
Ovarian cancer is a fatal gynecological malignancy. Although first-line chemotherapy and
surgical operation are effective treatments for ovarian cancer, its clinical management …
surgical operation are effective treatments for ovarian cancer, its clinical management …